Shareholders meeting

LINCOLN PHARMACEUTICALS LTD. HEALTHCARE FOR ALL Date: September 30, 2026 To To The Manager, The Manager, Listing Department, The Department of Corporate Service, National Stock Exchange of India Limited, (NSE) BSE Limited, (BSE) Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Phiroze Jeejeebhoy Tower, Bandra (E), Mumbai – 400 051. Dalal Street, Mumbai – 400 001. Scrip Code – LINCOLN Scrip Code – 531633 Dear Sir / Madam, Sub: Proceedings of the 32nd Annual General Meeting of the Company - Regulation 30 of SEBI (LODR) Regulations 2015. Meeting start time: 11:00 A.M S. No. Name Designation Directors 1. Mr. Mahendrabhai Gulabdas Patel Managing Director 2. Mr. Munjal Mahendrabhai Patel Whole Time Director 3. Mr. Ashish Rajanikant Patel Whole Time Director 4. Mr. Hashmukhbhai Ishwarlal Patel Whole Time Director 5. Mr. Rajanikant G. Patel Non-Executive Non-Independent Director 6. Mr. Saurin Parikh Independent Director 7. Ms. Seema Mehta Independent Woman Director & Chairperson of Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee Associate Company Secretary, Chief Financial Officer, Statutory Auditors, Secretarial Auditors and Scrutinizer also attended the meeting. Total 80 shareholders attended the meeting through VC. The Associate Company Secretary welcomed all the shareholders present and informed that, Mr. Kishor Shah, Non-Executive Director & Chairman of the board could not attend the meeting due to personal reasons hence Mr. Mahendra G. Patel was unanimously elected by Directors themselves to presid over the meeting to chair the 32nd Annual General Meeting. Mr. Naresh Suthar also could not join the meeting due to preoccupancy. It was further informed that the meeting was being conducted through video conferencing in compliance with the applicable circulars issued by the Ministry of Corporate Affairs and SEBI. Shareholders were also apprised that all AGM-related documents, as referred to in the Annual Report, along with the statutory registers, were made available for electronic inspection during the meeting. Upon confirming the presence of the requisite quorum, Mr. Mahendra Patel, Chairman of the Company, assumed the Chair and commenced the proceedings of the 32nd Annual General Meeting. He warmly welcomed all shareholders attending the meeting. Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India "i® Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com l Website: www.lincolnpharma.com Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721. Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com .,,. lntertek '" LINCOLN PHARMACEUTICALS LTD. HEALTHCARE FOR ALL The Chairman then addressed the shareholders, providing an overview of the current business. He further apprised about performance during the financial year ended March 31, 2026, and shared insights into the future outlook and growth prospects. It was further informed that the Annual Report for the year 2025-26 containing the audited financial statements (both standalone and consolidated) for the year ended March 31, 2026, Board's and Auditors’ report had been sent through electronic mode on September 05, 2026 to all the shareholders whose e-mail address are registered with the Company/ Depository Participant(s). Thereafter, with the permission of the Chair and shareholders present, the Associate Company Secretary took the Notice as read and it was further informed that Auditors’ Report and Secretarial Audit Report did not contain any qualifications, observations or adverse remarks. Thereafter, the Associate Company Secretary requested the pre-registered shareholders to raise their queries and all the queries raised by the shareholders were addressed satisfactorily by the Mr. Munjal M. Patel, Whole Time Director of the meeting. The Associate Company Secretary then informed the shareholders that pursuant to the provisions of Section 108 of the Companies Act, 2013, read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (as amended) and Regulation 44 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (as amended), and the MCA Circulars, the Company has provided the facility to shareholders to exercise their right to vote by electronic means through remote e- voting and voting during the AGM through CSDL. Remote E-Voting facility was provided from Saturday, 26th September, 2026 (9:00 am IST) to Tuesday, 29th September, 2026 (5:00 pm IST). The Associate Company Secretary further informed that those shareholders who were not able to vote through remote e-voting were requested to e-vote at the venue of this Annual General Meeting which will be available after the meeting. Further, the following items of businesses as set out in the Notice convening the 32nd AGM were recommended for members' consideration and approval: Ordinary Businesses: 1. To receive, consider and adopt Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year Ended March 31, 2026 together with the Auditors’ Report thereon and the Report of the Board of Directors of the Company. – Ordinary Resolution 2. To declare dividend at Rs. 1.80 (18%) per equity share for the financial year 2025-26. – Ordinary Resolution 3. To appoint a Director in place of Mr. Hashmukh I. Patel [DIN: 00104834], who retires by rotation and being eligible offers himself for re-appointment as a Director. – Ordinary Resolution 4. To appoint a Director in place of Mr. Munjal Mahendrabhai Patel [DIN: 02319308], who retires by rotation and being eligible offers himself for re-appointment as a Director. – Ordinary Resolution Special Businesses: 5. Ratification of remuneration payable to Kiran J. Mehta & Co., Cost Accountants (FRN: 000025) for the Financial Year ending on March 31, 2027. – Ordinary Resolution The Associate Company Secretary further informed that Mr. Umesh Parikh, Practicing Company Secretary to act as the Scrutinizer, to scrutinize the e-voting process and voting during the AGM. The results of the remote e-voting and voting during the AGM, shall be submitted by the Scrutinizer within 2 working days of the conclusion of the AGM. Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India "i® Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com l Website: www.lincolnpharma.com Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721. Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com .,,. lntertek '" LINCOLN PHARMACEUTICALS LTD. HEALTHCARE FOR ALL Thereafter, the Chairman of the meeting authorized the Associate Company Secretary to receive and declare the results and submit the same to the Stock Exchange(s). All the resolutions as per the Notice of 32nd AGM, if passed by the shareholders with requisite majority, are deemed to be passed on the date of the 32nd AGM i.e. September 30, 2026. The Associate Company Secretary of the meeting, thanked all the shareholders for their presence and support for the 32nd Annual General Meeting and the meeting stood closed at 11:40 A.M. We request you to take note of the same. Thanking you, Yours faithfully, For Lincoln Pharmaceuticals Ltd. Trusha Shah Company Secretary & Compliance Officer Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India "i® Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288 E-mail: info@lincolnpharma.com l Website: www.lincolnpharma.com Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721. Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com .,,. lntertek '"